Clin2
NCT07361874Possibly a fitRecruiting

Adrenal surgery vs semaglutide for mild cortisol excess

Mild Autonomous Cortisol Secretion (MACS)Autonomous Cortisol Secretion (ACS)Subclinical Cushing'sMild Autonomous Cortisol Excess

Part of Cancer, Hormones & metabolism clinical trials.

This study tests whether removing a small adrenal tumor or taking a diabetes/weight-loss medication (semaglutide) works better to improve health in people with mild hormone problems. It may help if you have an adrenal nodule causing slight cortisol overproduction or if you have obesity and related conditions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
75 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have a small adrenal growth (adenoma) that causes mild cortisol excess, or you have obesity with at least two heart/metabolic problems (like high blood pressure or diabetes)
  • If you have the adrenal growth, you are willing to delay surgery for 6 months if assigned to the medication group
  • You have not used semaglutide or similar drugs in the last 90 days
  • Your weight has been stable (no more than about 11 pounds change) in the last 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07268222Recruiting· Phase 4
Comparing two drugs for metabolic autonomous cortisol secretion

This trial tests whether metyrapone or osilodrostat works better for people with MACS, a condition where the adrenal glands produce too much cortisol on their own. The goal is to help you and your doctor choose the best treatment.

Athens
NCT07573163Recruiting· Phase 2
Tirzepatide after adrenal surgery for mild cortisol condition

This trial tests if tirzepatide can help with weight and blood pressure after you have surgery to remove an adrenal gland that's making too much cortisol. It may be a good option if you still have health issues like high blood pressure or obesity after surgery.

Pittsburgh, Pennsylvania
NCT07104812Recruiting· Phase 2
Testing low-dose osilodrostat for mild cortisol excess

This study tests whether a low dose of the drug osilodrostat can help people with mild cortisol excess (MACS) caused by benign adrenal tumors. It may improve related health problems like high blood pressure, diabetes, or bone thinning.

Rochester, Minnesota
NCT06344143Recruiting
Detecting mild hormone overproduction from adrenal tumors

This study looks for a mild form of hormone overproduction (called autonomous cortisol secretion) in people who have a benign growth on their adrenal gland. You will undergo a blood test to measure how well your body suppresses cortisol after taking a single dose of dexamethasone.

Cleveland, Ohio
NCT07138274Not yet recruiting· Phase 2
Metyrapone study for mild cortisol excess

This study tests if a medication called metyrapone can help people with mild autonomous cortisol secretion (MACS), a condition where your body makes too much cortisol. It looks at whether the drug improves related health problems like high blood pressure, diabetes, or bone issues.

NCT07513168Recruiting· Phase 4
Low-dose semaglutide for weight loss in obese adults

This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.

Hyderābād, Sindh

Hear when a new Mild Autonomous Cortisol Secretion (MACS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.